Patent · US Active

Inhibitors of JAK

US8618103B2 · kind B2 · utility

3Cited by
1References
27Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 9, 2010
Grant dateDec 31, 2013
Priority date
Expiry dateJun 17, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D513/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to the use of novel compounds of Formula I,wherein the variables m, n, p, q, Q, r, R, R′, X, X′, Y, Z1, Z2, and Z3 are defined as described herein, which inhibit JAK and are useful for the treatment of auto-immune and inflammatory diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.